The NeuroStar Transcranial Magnetic Stimulation Therapy system is the first TMS Therapy device cleared by the FDA for the treatment of depression. TMS Therapy is a non-systemic (does not circulate in the bloodstream) and non-invasive (does not involve surgery) form of neuromodulation, which stimulates nerve cells in the area of the brain thought to control mood, by delivering highly-focused MRI-strength magnetic pulses.​

TMS Technician: Alyse Walker

Neurostar Transcranial Magnetic Stimulation

Office Manager: Anita Trujillo

Medical director: Jefferson K. Davis, MD, MA